论文部分内容阅读
目的：探讨子宫动脉栓塞治疗子宫粘膜下肌瘤的疗效，并且评估在临床上的治疗疗效安全性。方法：选取我院2013年6月—2014年6月间妇产科子宫肌瘤患者住院患者，共100例，将100例患者按照随机分配的原则分为两组，观察组和对照组各50例。其中，对照组患者按早妇产科常科室子宫肌瘤常规治疗，药物保守治疗，观察组患者则是采用子宫动脉栓塞治疗。结果：两组患者在经过治疗后，经对比，发现观察组患者在治疗后的3个月、6个月以及1年期间的复查结果，子宫肌瘤的大小在B超下发现明显小于对照组，两组结果比较有明显的差异，其中观察组患者的治疗疗效为92.0%，观察组为72.0%，P<0.05，具有统计学意义。同时观察两组患者治疗的安全性，对患者卵巢功能的影响，观察组明显小于对照组，P<0.05。结论：子宫动脉栓塞治疗子宫粘膜下肌瘤的效果显著，明显优于药物保守治疗组，同时对卵巢功能影响小，值得临床推广。“,”Objective To study the curative effects of uterine arterial embolization in hysteromyoma and evaluate the safety of clinical treatment.Method 100 in-patients with hysteromyoma treated from June 2013 to June 2014 in our Obstetrics and Gynecology Department were selected and randomly divided into observation group and control group, 50 cases each group. The control group received the conventional and conservative treatment. The control group received uterine arterial embolization therapy. Result:After 3m, 6m and 1y of treatment, the Results Were reviewed. Based on Type-B ultrasonic, the size of hysteromyoma of observation group was significantly smaller than that of control group (P<0.05). The curative efficacy of observation group (92.0%) was significantly higher than that of control group (72.0%) (P<0.05);according to curative safety, the influencing rate for ovarian function of observation group was significantly lower than that of control group(P<0.05). Conclusion For hysteromyoma, uterine arterial embolization has a better treatment effect compared with conservative treatment and has less impact on ovarian function. It is worthy of clinical promotion.